These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37667962)

  • 1. Independent risk factors for COVID-19-associated coagulopathy.
    Tor YB; Ozbalak M; Kalayoglu-Besisik S; Aksoy E; Cagatay AA; Gul A; Erelel M; Senkal N; Medetalibeyoglu A; Kose M; Tukek T
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7851-7860. PubMed ID: 37667962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Intravascular Coagulation Score and Sepsis-induced Coagulopathy Score in Prediction of COVID-19 Severity: A Retrospective Analysis.
    Kapoor M; Panda PK; Saini LK; Bahurupi Y
    Indian J Crit Care Med; 2021 Dec; 25(12):1357-1363. PubMed ID: 35027794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID19 coagulopathy in Caucasian patients.
    Fogarty H; Townsend L; Ni Cheallaigh C; Bergin C; Martin-Loeches I; Browne P; Bacon CL; Gaule R; Gillett A; Byrne M; Ryan K; O'Connell N; O'Sullivan JM; Conlon N; O'Donnell JS
    Br J Haematol; 2020 Jun; 189(6):1044-1049. PubMed ID: 32330308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis and Coagulopathy in COVID-19.
    Gómez-Mesa JE; Galindo-Coral S; Montes MC; Muñoz Martin AJ
    Curr Probl Cardiol; 2021 Mar; 46(3):100742. PubMed ID: 33243440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IL-6, ferritin, and coagulopathy in Covid-19 clinical progression.
    Harahap AT; Irawan C; Susilo A; Harimurti K; Gathmyr D; Shatri H; Lubis AM; Nainggolan L; Abdullah M
    F1000Res; 2022; 11():1285. PubMed ID: 37841828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
    Savla SR; Prabhavalkar KS; Bhatt LK
    Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIC, SIC or CAC - the haemostatic profile in COVID-19 patients hospitalised in the intensive care unit: a single-centre retrospective analysis.
    Pluta J; Pihowicz A; Horban A; Trzebicki J
    Anaesthesiol Intensive Ther; 2021; 53(2):108-114. PubMed ID: 34284551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
    Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
    J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
    Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of vitamin D were associated with coagulopathy among hospitalized coronavirus disease-19 (COVID-19) patients: A single-centered study in Indonesia.
    Susianti H; Wahono CS; Rahman PA; Pratama MZ; Wulanda IA; Hartanti KD; Dewi ES; Handono K
    J Med Biochem; 2021 Sep; 40(4):341-350. PubMed ID: 34744508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peculiarities of blood coagulation disorders in patients with COVID-19].
    Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
    Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding COVID-19-associated coagulopathy: From PIC to SIC or DIC.
    Wang Z; Gao X; Miao H; Ma X; Ding R
    J Intensive Med; 2021 Jul; 1(1):35-41. PubMed ID: 36943814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated Coagulopathy and Thromboembolism: Determination of Their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients.
    Naqvi IH; Alam MT; Rehan M; Mahmood K; Aurangzeb M; Talib A
    Curr Vasc Pharmacol; 2022; 20(1):77-86. PubMed ID: 34649490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study.
    Pereyra D; Heber S; Schrottmaier WC; Santol J; Pirabe A; Schmuckenschlager A; Kammerer K; Ammon D; Sorz T; Fritsch F; Hayden H; Pawelka E; Krüger P; Rumpf B; Traugott MT; Glaser P; Firbas C; Schörgenhofer C; Seitz T; Karolyi M; Pabinger I; Brostjan C; Starlinger P; Weiss G; Bellmann-Weiler R; Salzer HJF; Jilma B; Zoufaly A; Assinger A
    Cardiovasc Res; 2021 Dec; 117(14):2807-2820. PubMed ID: 34609480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy during COVID-19 infection: a brief review.
    Cunningham RM; Johnson Moore KL; Moore JS
    Clin Exp Med; 2023 Jul; 23(3):655-666. PubMed ID: 36121504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
    Levi M; Iba T
    Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.